## Treatment of Lichen Planus: First-Line Management ### Clinical Context This patient has **generalized lichen planus** with: - Cutaneous involvement (dorsal hands, forearms, lower legs) - Oral involvement (white lacy patches) - Significant pruritus (a hallmark symptom) - No systemic complications ### Treatment Algorithm for Lichen Planus ```mermaid flowchart TD A[Lichen Planus Diagnosis Confirmed]:::outcome --> B{Extent & Severity?}:::decision B -->|Localized, non-erosive| C[Topical Corticosteroids]:::action B -->|Generalized or erosive| D[Systemic Therapy]:::action C --> E[Add Antihistamine for Pruritus]:::action D --> F[Oral Corticosteroids ± Retinoids]:::action E --> G[Monitor for Response]:::outcome F --> H{Improvement?}:::decision H -->|Yes| I[Taper & Maintain]:::action H -->|No| J[Add Methotrexate or Azathioprine]:::action ``` ### First-Line Treatment Rationale **High-Yield:** Treatment of lichen planus is **stepwise and site-dependent**: | Disease Extent | First-Line Treatment | Rationale | |---|---|---| | **Localized cutaneous** | Topical potent corticosteroid (Class II–III) | High local concentration, minimal systemic absorption | | **Generalized cutaneous** | Topical corticosteroid + oral antihistamine | Addresses both inflammation and pruritus | | **Erosive oral** | Topical corticosteroid rinse + systemic corticosteroids | Mucosal penetration and systemic control | | **Refractory** | Oral retinoids, methotrexate, azathioprine | Steroid-sparing agents | ### Specific Agent Selection **Key Point:** For this patient with generalized but non-erosive disease: 1. **Topical corticosteroid:** Clobetasol propionate 0.05% cream or fluocinonide (Class II potency) — apply to affected areas twice daily 2. **Antihistamine:** Cetirizine 10 mg or loratadine 10 mg daily — controls pruritus and improves sleep 3. **Oral hygiene:** Chlorhexidine rinse for oral lesions **Clinical Pearl:** Pruritus in lichen planus is often severe and can be the most bothersome symptom. Antihistamines (especially sedating ones at night) significantly improve quality of life and reduce excoriation. ### Why Systemic Therapy Is NOT First-Line Here **Warning:** Oral corticosteroids and methotrexate are reserved for: - Erosive oral lichen planus - Extensive, severely symptomatic cutaneous disease refractory to topical therapy - Lichen planopilaris or nail lichen planus (high risk of permanent scarring) This patient has generalized but non-erosive disease — systemic therapy carries unnecessary risk of adverse effects (immunosuppression, metabolic effects) without added benefit. ### Expected Outcomes - Topical corticosteroids: 60–80% improvement in 4–6 weeks - Antihistamines: Rapid relief of pruritus within days - Oral lesions: May take 8–12 weeks to resolve - Relapse rate: 10–20% after treatment cessation 
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.